* Any views expressed in this article are those of the author and not of Thomson Reuters Foundation. DES MOINES, Iowa (CIMMYT) – Gene editing technology could revolutionize the way scientists breed high-yielding drought, disease and pest resistant, quality plant seeds, greatly reducing the time it currently takes to develop new varieties, said a panel […]

Sharp investors are usually looking for true bargains in the stock market. Finding these stocks can help give the stock portfolio a boost. Shares of CRISPR THERAPTC (:CRSP) have come into focus recently. Checking in on the stock, we can see that it has been trading near the $19.01 level. Going forward, the investment community […]

Sarepta $SRPT announced this morning that it’s teaming up with Duke University to explore new CRISPR-based methods in the hunt for an effective Duchenne muscular dystrophy therapy. The company says it’s specifically interested in DMD, the rare and lethal condition it aimed to treat with its drug Exondys51. But remember, Sarepta got a controversial regulatory […]

Disruptive bioengineering – changing the way cells interact with each other. Credit: Shutterstock Researchers at the MRC Weatherall Institute of Molecular Medicine have developed a new platform based on the revolutionary CRISPR/Cas9 technology, to alter the way human cells respond to external signals, and provide new opportunities for stopping cancer cells from developing. Cells are […]

Sarepta has been signing a series of new R&D pacts since its controversial Duchenne muscular dystrophy (DMD) drug approval last fall, and today it’s penned a deal for one of the hottest research areas around: CRISPR. In a deal with Duke University (financial terms were not disclosed), Sarepta gains an option for an exclusive license for […]

AsianScientist (Oct. 31, 2017) – In a study published in the Proceedings of the National Academy of Sciences, scientists in China have created genetically modified pigs that are lean and more resistant to cold. There are two distinct types of fat in most mammals: white adipose tissue (WAT) for energy storage and brown adipose tissue […]

Case studies with Zika virus and tuberous sclerosis presented at next annual industry summit on 3D Cell Culture SMi Group will welcome the expertise of Max Salick when he presents case study insight at the second annual conference on 3D Cell Culture which returns to Central London on 21st and 22nd February in 2018. Max […]

NEWPORT BEACH, CA–(Marketwired – October 31, 2017) – NuLife Sciences (OTCQB: NULF) today announced the signing of a letter of intent to undertake a formal merger with Ensysce Biosciences of San Diego, California, a clinical stage company with delivery platforms for both small and large molecule therapies. Ensysce’s BIO-MD™ is a prodrug delivery platform that […]

First company to demonstrate dose-dependent CRISPR/Cas9 liver editing in non-human primates, including editing of over 20 percent in certain animals, following systemic delivery of Intellia’s proprietary, non-viral, lipid nanoparticle delivery system Well-tolerated safety profile observed to date in non-human primates after single and repeat doses, with rapid clearance of all CRISPR/Cas9 cargo and cationic lipid […]

Around 20 million years ago, for unknown reasons, wild pigs lost an important metabolic gene known as uncoupling protein 1 (UCP1). In most mammals this gene plays a major role in generating body heat for thermoregulation, and lack of UCP1 has led to some unusual physiological traits in all modern domestic and wild pig species1. […]